Erik M. Schlicht

Publications by Year

Research Areas

Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Pediatric Hepatobiliary Diseases and Treatments, BRCA gene mutations in cancer, Inflammatory Bowel Disease

Most-Cited Works

• → Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease(2016)374 cited
• → International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways(2015)306 cited
• → Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants(2012)156 cited
• → Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning(2018)144 cited
• → Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation(2020)94 cited
• → A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease(2015)65 cited
• → Primary Biliary Cirrhosis Is Associated With a Genetic Variant in the 3′ Flanking Region of the CTLA4 Gene(2008)64 cited
• → Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis(2007)49 cited
• → Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients(2013)43 cited
• → Questionnaire based assessment of risk factors for primary biliary cirrhosis(2013)42 cited